U.S. markets closed

Sun Pharmaceutical Industries Limited (SUNPHARMA.NS)

NSE - NSE Real Time Price. Currency in INR
Add to watchlist
528.85-0.10 (-0.02%)
At close: 3:29PM IST

Sun Pharmaceutical Industries Limited

Sun House
Plot No. 201 B/1 Western Express Highway Goregaon (East)
Mumbai 400063
India
91 22 4324 4324
http://www.sunpharma.com

Sector(s)Healthcare
IndustryDrug Manufacturers—Specialty & Generic
Full Time Employees

Key Executives

NameTitlePayExercisedYear Born
Mr. Dilip Shantilal ShanghviMD & Exec. Director43.08MN/A1955
Mr. C. S. MuralidharanChief Financial Officer38.89MN/A1963
Mr. Sailesh Trambaklal DesaiWhole Time Director15.81MN/A1954
Mr. Kalyanasundaram SubramanianCEO of India Bus. and Emerging Markets & Whole-Time Director49.74MN/A1954
Mr. Sunil R. AjmeraCompany Sec.14.01MN/AN/A
Amounts are as of December 31, 2020 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.

Description

Sun Pharmaceutical Industries Limited, a generic pharmaceutical company, develops, manufactures, and markets branded and generic formulations and active pharmaceutical ingredients (APIs) in India and internationally. The company offers formulations in various therapeutic areas, including central nervous system, dermatology, cardiology, oncology and ophthalmic, neuro-psychiatry, gastroenterology, anti-infectives, diabetology, pain/analgesics, vitamins/minerals/nutrients, respiratory, gynaecology, urology, opthalomology, orthopaedic, nephrology, dental, and other areas. It also provides APIs for anti-cancers, peptides, steroids, sex hormones, and controlled substances, as well as over-the-counter products. Sun Pharmaceutical Industries Limited was founded in 1983 and is based in Mumbai, India.

Corporate Governance

Sun Pharmaceutical Industries Limited’s ISS Governance QualityScore as of December 8, 2019 is 10. The pillar scores are Audit: 8; Board: 8; Shareholder Rights: 5; Compensation: 9.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.